Fidelity's increased passive stake signals continued institutional confidence but no change in control intent. Monitor for any future conversion to a 13D filing, which would indicate activist intentions.
MRNA drugs
MRNA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 5 $241.46entry
- T+1 · 11d ago +5.27%α +4.96% · $254.19
- T+5 · 5d ago −4.19%α −7.48% · $231.35
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G for Moderna, reporting beneficial ownership of 58,929,948.15 shares (14.8% of common stock) as of September 30, 2026. This is an increase from the prior filing (FMR LLC reported 5% or greater ownership in August 2026, but the exact prior stake percentage is not stated in the provided documents). The filing remains passive, with no indication of activist intent.
Key Financial Metrics
Key Facts
- FMR LLC (Fidelity) reported beneficial ownership of 58,929,948.15 shares of Moderna common stock as of September 30, 2026.
- The stake represents 14.8% of outstanding shares.
- This is an amendment to a prior Schedule 13G filed on August 12, 2026, indicating an increase in the reported position.
- The filing is made under Rule 13d-1(b), confirming passive investment intent.
- Fidelity Management & Research Company LLC is the entity that beneficially owns 5% or greater of the shares.
Financial Impact
FMR LLC holds 58.9M shares, representing 14.8% of Moderna's outstanding stock. At a market cap of $91.2B, the stake is valued at approximately $13.5B.
Risk Factors
- No specific risks identified from this passive stake filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002811 |
| Document: 0000315066-26-002811-index-headers.html | 0000315066-26-002811 |
| Document: 0000315066-26-002811-index.html | 0000315066-26-002811 |
| Document: 0000315066-26-002811.txt | 0000315066-26-002811 |
Track record
26 reports on MRNA
6 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +14.15% at T+60 after the Mar 5, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $217.29 Now $215.27 −0.93% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 3/10 Entry $222.50 Now $215.27 −3.25% settles Nov 17
- Nov 6, 202610d ago 8-K Bullish 7/10 Entry $254.19 to $269.00 Now $215.27 −15.31% ▲ +5.83% +3.46% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Viewing Entry $241.46 to $254.19 Now $215.27 −10.85% ▲ +5.27% +4.96% vs SPY
- Oct 28, 202619d ago Institutional Cluster Neutral 3/10 Entry $214.17 to $222.76 Now $215.27 +0.52% ▲ +4.01% +4.40% vs SPY
- Oct 27, 202620d ago ANALYST-DOWNGRADE Bearish 4/10 Entry $207.97 to $214.17 Now $215.27 −3.51% ▼ −2.98% −2.63% vs SPY
- Sep 30, 20266w ago 8-K Neutral 3/10 Entry $192.57 to $188.94 Now $215.27 +11.79% ▼ −1.89% −2.06% vs SPY
- Sep 30, 20266w ago ANALYST-DOWNGRADE Bearish 4/10 No price data
- Sep 16, 20268w ago Insider Cluster Bearish 5/10 Entry $158.07 to $154.04 Now $215.27 −36.19% ▲ +2.55% +2.43% vs SPY
- Sep 3, 202610w ago ANALYST-DOWNGRADE Bearish 6/10 Entry $148.87 to $145.55 Now $215.27 −44.60% ▲ +2.23% +1.84% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers